Final Program in it's entirety - MyGirlsBlood
Final Program in it's entirety - MyGirlsBlood
Final Program in it's entirety - MyGirlsBlood
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Posters, Tuesday and Wednesday<br />
Index of Poster Presenters cont’d<br />
VENOUS ACCESS<br />
34P04<br />
Outcomes of Portacaths <strong>in</strong> Children with Hemophilia: A<br />
Comprehensive Care Centre Approach<br />
Efford J, Baker K, Henderson L, Liesner R, Khair K,<br />
Mathias M<br />
Great Ormond Street Hospital Haemophilia Comprehensive<br />
Care Centre, London, U.K.<br />
34P05<br />
Peripheral Arteriovenous Shunts for Venous Access <strong>in</strong><br />
Children with Hemophilia<br />
Male C1 , Thom K1 , Hölzenbe<strong>in</strong> T2 , Zwiauer K3 , Endres G4 1Department of Paediatrics, Medical University of Vienna,<br />
Austria, 2Department of Vascular Surgery, Landeskrankenhaus<br />
Salzburg, Austria, 3Department of Pediatrics, Landeskl<strong>in</strong>ikum<br />
St. Pölten, Austria, 4Department of Pediatrics, Landeskran -<br />
kenhaus Bregenz, Austria<br />
34P06<br />
Incidence of Sports <strong>in</strong> Patients with Hemophilia A and<br />
Inhibitor<br />
Torres Ortuño AI, Cuesta Barriuso R y Moreno MM<br />
Asociación Regional Murciana De Hemofilia, Murcia, Spa<strong>in</strong><br />
34P07<br />
Relationship between the Management of Port-A-Cath <strong>in</strong><br />
Children and Degree of Parental Stress<br />
Torres Ortuño AI, Cuesta Barriuso R y Moreno MM<br />
Asociación Regional Murciana De Hemofilia, Murcia, Spa<strong>in</strong><br />
34P08<br />
Captur<strong>in</strong>g Daily Home Treatment and Quality of Life<br />
Assessments <strong>in</strong> Congenital Hemophilia with Inhibitors (CHwI):<br />
Design, Disposition and Implications of the Dos<strong>in</strong>g<br />
Observational Study <strong>in</strong> Hemophilia (DOSE)<br />
G. Young1 , D.L. Cooper2 , K. Hoffman3 , J. Kabawat3 and C.T.<br />
Wilke4 .<br />
1Childrens Hospital of Los Angeles, Los Angeles, California<br />
U.S.A., 2Novo Nordisk Inc., Pr<strong>in</strong>ceton, New Jersey U.S.A.,<br />
3Outcome Sciences, Inc., Cambridge, Massachusetts U.S.A.,<br />
4University of Ill<strong>in</strong>ois, Chicago, Chicago, Ill<strong>in</strong>ois U.S.A.<br />
34P09<br />
Improved Chance of Success? Hand Exercise and IV Access<br />
Holl<strong>in</strong>gdrake O, Stewart M, Zeiss<strong>in</strong>k B<br />
Queensland Haemophilia Centre, Queensland, Australia<br />
34P10<br />
Teach<strong>in</strong>g Intravenous Access: A Survey of Practice<br />
Patterns <strong>in</strong> Australia<br />
Zeiss<strong>in</strong>k B<br />
Australian Haemophilia Nurse’s Group, Queensland,<br />
Australia<br />
88<br />
VON WILLEBRAND DISEASE<br />
35P02<br />
A New Immunoturbidimetric Mono-Reagent Kit for<br />
VWF:Ag <strong>in</strong> Q Hemostasis Analyzer<br />
Ambros R 1 , Gassó S 2 , Montan<strong>in</strong>i V 1 , Berga V 2 , Civit G 1<br />
1 Diagnostic Grifols and 2 Sp<strong>in</strong>react, Barcelona, Spa<strong>in</strong><br />
35P03<br />
Presence of a Common Haplotype <strong>in</strong> the Turkish VWD<br />
Patients<br />
Berber E 1 , Dagdemir A 2 , Pehlevan F 2 , Ak<strong>in</strong> M 1 , Kavakli K 1 ,<br />
Caglayan S 3<br />
1 Ege University, 2 Halic University, and 3 Bogazici University,<br />
Istanbul, Turkey<br />
35P04<br />
Von Willebrand Disease Prophylaxis Network<br />
Abshire T1 , Bowen J2 , Berntorp E3 1 2 BloodCenter of Wiscons<strong>in</strong>, Milwaukee, WI, U.S.A., Rho,<br />
Inc., Chapel Hill, NC, U.S.A., 3Centre for Thrombosis and<br />
Haemostasis, Malmö University Hospital, Lund University,<br />
Malmö, Sweden<br />
35P05<br />
Prospective Validation of a Modified von Willebrand Score<br />
<strong>in</strong> Children<br />
Bidl<strong>in</strong>gmaier C1 , Olivieri M1 , Budde U2 , Kurnik K1 1Children’s University Hospital Munich, Germany,<br />
2Coagulation Laboratory Hamburg, Germany<br />
35P06<br />
Focus On Gynecological & Obstetrics Procedures In<br />
Women with von Willebrand Disease (VWD): Data From A<br />
French Cl<strong>in</strong>ical Postmarket<strong>in</strong>g Survey Of A High-Purity von<br />
Willebrand Factor Concentrate with a Low Factor VIII<br />
Content<br />
Borel-Derlon A1 , Goudemand J2 , Boyer-Neumann C3 , Sié<br />
P4 , Bertrand M5 , Post<br />
Market<strong>in</strong>g Study Group6 , Henriet C7 , Bridey F7 ,<br />
Chatelanaz C7 1Haemophilia Centre, University Hospital Centre, Caen,<br />
2Haemophilia Centre, University Hospital Centre, Lille,<br />
3Haematology Laboratory, A-Béclère Hospital, Clamart,<br />
4Haemophilia Centre, University Hospital Centre, Toulouse,<br />
5Haemophilia Centre, University Hospital Centre, Besançon,<br />
6 7 French HTC, LFB, LES ULIS, France